Market News

Astrotech (ASTC) Reaches $1.85 Yearly Low; Avenue Therapeutics (ATXI) Shorts Decreased By 6.45%

Astrotech Corporation (NASDAQ:ASTC) Logo

Avenue Therapeutics Inc (NASDAQ:ATXI) had a decrease of 6.45% in short interest. ATXI’s SI was 5,800 shares in May as released by FINRA. Its down 6.45% from 6,200 shares previously. With 21,600 avg volume, 0 days are for Avenue Therapeutics Inc (NASDAQ:ATXI)’s short sellers to cover ATXI’s short positions. The SI to Avenue Therapeutics Inc’s float is 0.09%. The stock decreased 0.46% or $0.02 during the last trading session, reaching $4.35. About 8,952 shares traded. Avenue Therapeutics, Inc. (NASDAQ:ATXI) has 0.00% since May 17, 2017 and is . It has underperformed by 11.55% the S&P500.

The stock of Astrotech Corporation (NASDAQ:ASTC) hit a new 52-week low and has $1.79 target or 3.00% below today’s $1.85 share price. The 5 months bearish chart indicates high risk for the $7.60 million company. The 1-year low was reported on May, 17 by If the $1.79 price target is reached, the company will be worth $227,970 less. The stock decreased 4.14% or $0.08 during the last trading session, reaching $1.85. About 19,650 shares traded. Astrotech Corporation (NASDAQ:ASTC) has declined 59.85% since May 17, 2017 and is downtrending. It has underperformed by 71.40% the S&P500.

Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes an intravenous formulation of tramadol HCI principally for use in the acute/intensive care hospital setting. The company has market cap of $45.91 million. The Company’s product candidate is IV Tramadol for the treatment of post-operative pain. It currently has negative earnings. The firm was founded in 2015 and is based in New York, New York.

Another recent and important Avenue Therapeutics, Inc. (NASDAQ:ATXI) news was published by which published an article titled: “Avenue Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights” on May 03, 2018.

Investors sentiment decreased to 0 in Q4 2017. Its down 0.75, from 0.75 in 2017Q3. It worsened, as 10 investors sold Astrotech Corporation shares while 2 reduced holdings. 0 funds opened positions while 0 raised stakes. 231,829 shares or 89.88% less from 2.29 million shares in 2017Q3 were reported. Messner & Smith Theme Value Invest Mgmt Ltd Ca reported 4,620 shares. Beck Capital Ltd Liability Co stated it has 227,209 shares.

Leave a Reply

Your email address will not be published. Required fields are marked *